logo
logo

Genixus Closes $20Mm In Financing To Accelerate Commercialization Of Injectables Portfolio

Genixus Closes $20Mm In Financing To Accelerate Commercialization Of Injectables Portfolio

01/18/22, 9:23 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgkannapolis
Money raised
$20 million
GENIXUS, a pharmaceutical company focused on transforming acute and critical care medicines, today announced the closure of $20MM in financing to support development & commercialization of its portfolio of novel ready-to-administer products for the hospital setting.

Company Info

Company
Genixus
Location
kannapolis, north carolina, united states
Additional Info
GENIXUS is a development stage pharmaceutical company working to transform acute and critical care medicines through advanced manufacturing and innovative delivery systems. Leveraging the highest-quality biopharmaceutical manufacturing standards and innovative point-of-care design, GENIXUS is changing care delivery and helping healthcare professionals to achieve better quality outcomes for patients. For more information, visit www.genixus.com and follow the company on LinkedIn. SOURCE GENIXUS